Halozyme Therapeutics (NasdaqGS:HALO) Update / briefing Transcript
Halozyme(US:HALO)2026-01-28 14:32Halozyme Therapeutics (NasdaqGS:HALO) Update / briefing January 28, 2026 08:30 AM ET Company ParticipantsBrendan Smith - DirectorCorinne Johnson - Managing DirectorDavid Risinger - Senior Managing DirectorHelen Torley - President and CEOJason Butler - Managing DirectorMichael DiFiore - Managing DirectorMohit Bansal - Managing DirectorNicole LaBrosse - CFOConference Call ParticipantsMitchell Kapoor - Director and Senior Biotechnology AnalystOperatorGood morning. My name is Eric, and I will be your conference ...